Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2985180 | The Journal of Thoracic and Cardiovascular Surgery | 2006 | 10 Pages |
Abstract
Patients with clinical stage I lung cancer staged by computed tomography and positron emission tomography benefit little from mediastinoscopy. The survival advantage it confers is very small and is dependent on the prevalence of N2 metastasis and the unproven superiority of induction therapy over adjuvant therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Bryan F. MD, Fabio MD, Barry A. MD, Jennifer Bell BSN, Richard J. MD, Nirmal MD, Joel D. MD, G. Alexander MD,